Update
Cambrex adding lab space, to hire 14 chemists
Cambrex Corporation continues to expand its analytical development capabilities as part of its strategic plan to increase capacity in North America.
Archives for January 31, 2018
CorePharma to reopen under new ownership following Impax sale
Impax Laboratories has sold its CorePharma facilities and equipment to a group of industry investors which aim to reestablish the company as a "preferred partner of choice," says new CEO.
FDA upgrades Kansas plant but Hospira’s legacy continues to haunt Pfizer
The US FDA has upgraded the status of Pfizer’s McPherson manufacturing, hit with a warning letter last year.
Japanese API maker accused of falsifying data by US FDA
The US FDA has slammed Daito Kasei Kogyo Co in a warning letter for data integrity issues.
Intas puts the fizz back into ex-Sanofi plant with generic effervescents
Intas Pharmaceuticals says it ‘worked hard’ over two years to bring an ex-Sanofi manufacturing facility back into production in Newcastle, UK.